[CLDX] YoY Annual Result on 31-Dec-2010 [#FY]

Stock
[CLDX] Celldex Therapeutics, Inc.
Announcement Date
09-Mar-2011
Financial Year
2010
Quarter
31-Dec-2010 [#FY]
Profit Trend
YoY- 93.07%
Quarter Report
CLDX's Result
CLDX's Financial Summary
View:
Show?
Annual Result
31/12/13 31/12/12 31/12/11 31/12/10 31/12/09 31/12/08 31/12/07 CAGR
Revenue 4,111 11,202 9,265 46,793 15,180 7,456 5,103 -3.53%
PBT -81,550 -59,123 -44,799 -2,533 -37,054 -62,256 -21,759 24.60%
Tax -819 -530 -446 -5,309 -529 27,001 -120 37.68%
NP -81,550 -59,123 -44,799 -2,533 -36,525 -47,501 -21,639 24.72%
Tax Rate - - - - - - - -
Total Cost 85,661 70,325 54,064 49,326 51,705 54,956 26,742 21.39%
Ratio Analysis
31/12/13 31/12/12 31/12/11 31/12/10 31/12/09 31/12/08 31/12/07 CAGR
NP Margin -1,983.70 -527.79 -483.53 -5.41 -240.61 -637.12 -424.05 29.29%
Per Share
31/12/13 31/12/12 31/12/11 31/12/10 31/12/09 31/12/08 31/12/07 CAGR
EPS -15.33 -15.37 -17.01 -1.19 -27.64 -50.12 -468.75 -43.42%
EPS Diluted -15.33 -15.37 -17.01 -1.19 -27.64 -50.12 -468.75 -43.42%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.